Statistics for Assessing Post-Marketing Requirements for Orphan Drugs: A Cross-Sectional Analysis of FDA and EMA Oversight : Clinical Pharmacology and Therapeutics

Total visits

views
Assessing Post-Marketing Requirements for Orphan Drugs: A Cross-Sectional Analysis of FDA and EMA Oversight : Clinical Pharmacology and Therapeutics 0

Total visits per month

views
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0